Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Humacyte, Inc. Common Stock

HUMA Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown
HUMA Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
HUMA Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
HUMA Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in HUMA holdings by institutional investors

Quarterly net insider trading by HUMA's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $50,000 Jul 20, 2026 Issue: Medicare/Medicaid Health Issues Defense
  • $50,000 Apr 21, 2026 Issue: Medicare/Medicaid Health Issues Defense
  • $50,000 Jan 20, 2026 Issue: Medicare/Medicaid Health Issues Defense
  • $50,000 Oct 21, 2025 Issue: Medicare/Medicaid Health Issues Defense
  • $10,000 Jul 13, 2025 Issue: Health Issues
  • $10,000 Apr 21, 2025 Issue: Health Issues
  • $10,000 Jan 19, 2025 Issue: Health Issues
  • $10,000 Jan 17, 2025 Issue: Budget/Appropriations
  • $10,000 Oct 21, 2024 Issue: Budget/Appropriations
  • $10,000 Oct 14, 2024 Issue: Health Issues
  • $10,000 Jul 19, 2024 Issue: Health Issues
  • $10,000 Oct 20, 2021 Issue: Medicare/Medicaid
  • $50,000 Jul 20, 2021 Issue: Medicare/Medicaid
  • $50,000 Apr 20, 2021 Issue: Medicare/Medicaid
  • $50,000 Jan 21, 2021 Issue: Medicare/Medicaid
  • $50,000 Oct 20, 2020 Issue: Medicare/Medicaid
  • $50,000 Jul 20, 2020 Issue: Medicare/Medicaid
  • $50,000 Apr 24, 2020 Issue: Medicare/Medicaid
  • $50,000 Apr 20, 2020 Issue: Medicare/Medicaid
  • $50,000 Oct 21, 2019 Issue: Medicare/Medicaid
  • $50,000 Jul 22, 2019 Issue: Medicare/Medicaid
  • $50,000 Apr 22, 2019 Issue: Medicare/Medicaid
  • $50,000 Jan 22, 2019 Issue: Medicare/Medicaid
  • $50,000 Oct 22, 2018 Issue: Medicare/Medicaid
  • $50,000 Jul 20, 2018 Issue: Medicare/Medicaid
  • $50,000 Apr 20, 2018 Issue: Medicare/Medicaid
  • $50,000 Jan 22, 2018 Issue: Medicare/Medicaid
  • $50,000 Oct 20, 2017 Issue: Medicare/Medicaid
  • $20,000 Jul 20, 2017 Issue: Medicare/Medicaid
  • $30,000 Jul 20, 2017 Issue: Medicare/Medicaid
  • $40,000 Apr 20, 2017 Issue: Medicare/Medicaid
  • $40,000 Jan 23, 2017 Issue: Medicare/Medicaid
  • $40,000 Oct 20, 2016 Issue: Medicare/Medicaid
  • $40,000 Jul 20, 2016 Issue: Medicare/Medicaid
  • $40,000 Apr 20, 2016 Issue: Medicare/Medicaid
  • $40,000 Jan 19, 2016 Issue: Medicare/Medicaid

Former government officials who have lobbied for HUMA

11 former government officials from 3 congressional offices at 5 lobbying firms have lobbied for HUMA, most recently Jul 21, 2026.

  • Brian Sutter House Staff Dir. W&M Health subcommittee, Chairman Dave Camp April'13-Dec'14. Professional Staff, W&M Health subcommittee, Chairman Dave Camp, Jan'11-April'13. Leg Dir. Rep Dave Camp, May'08-Jan'11. Leg Asst Rep Dave Camp, Feb'03-May'08. Staff Ast July'02 Formerly Dave Camp · CAPITOL HILL CONSULTING GROUP · Jul 21, 2026
  • Rick Boucher
    Christopher Davis House Staff Assistant, Legislative Assistant, Senior Legislative Assistant, and Legislative Director - Rep. Rick Boucher (2006-2011). Formerly with Rick Boucher · CAPITOL HILL CONSULTING GROUP · Jul 21, 2026
  • Emily Wilkinson-Holland Congress Staff -Rep. Price (2010-11), LA: Rep. Grimm (2011-12), Rep. Black (2012-13), Sen.Vitter (2013-2015), Sen. Heller (2015-17), Policy Adv. to the Sec.- Dept of HHS (3/2017-8/2017), Sr Advisor to Administrator - Ctrs for Medicare & Medicaid (8/17- 5/19). Formerly Price · CAPITOL HILL CONSULTING GROUP · Jul 21, 2026
  • Kimberlee Trzeciak Congress FDA. Dep. Commissioner; 8/23-1/25. Assoc. Commissioner Leg. Affairs; 2/2022-08/2023. House Com. Energy & Commerce: Chief Health Advisor, 2/22-4/19. Sen. Health Policy Advisor, 3/19-3/15. Rep. John D. Dingell - LD, 05/13-07/11. Sen. LA, 7/11-08/09, LA Formerly Health Policy Advisor · CAPITOL HILL CONSULTING GROUP · Jul 21, 2026
  • James R. Langevin
    Elizabeth Powell House Legislative Director for Rep. Jim Langevin 2001-2002 and Legislative Director for Rep. Juanita Millender-McDonald 1997-2001 Formerly with James R. Langevin · G2G CONSULTING · Oct 15, 2025
  • Christopher Cooper Congress Chief Appropriations Counsel,Chief of Staff,Legislative Director,Senior Legislative Assistant,Legislative Assistant for David Joyce (2013-2023) & Legislative Assistant/ Correspondent,Staff Assistant,Legislative Intern for Steven LaTourette(2011-2013) Formerly Chief Appropriations Counsel,Chief of Staff,Legislative Director,Senior Legislat · G2G CONSULTING · Oct 15, 2025
  • Richard Burr
    Michael Sorensen Senate New Scheduler and other positions, Sen. Richard Burr; Intern, Rep. John Boehner; Intern, Rep. Mike Kelly Formerly with Richard Burr · DLA PIPER LLP (US) · Sep 26, 2024
  • Colin Roskey Senate New Health Policy Advisor and Counsel, Senate Finance Committee Formerly Health Policy Advisor and Counsel, Senate Finance Committee · FEDERAL HEALTH POLICY STRATEGIES · Apr 17, 2023
See all 11 on the Revolving Door dashboard

HUMA Estimated quarterly lobbying spending

HUMA Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
HUMA Income Statement
HUMA Balance Sheet
HUMA Cash Flow
U.S. Patents

New HUMA patent grants

  • Patent Title: Tubular prostheses Nov. 18, 2025
  • Patent Title: Drawer system for cultivating tissue Jan. 14, 2025
  • Patent Title: System, apparatuses, devices and methods for straining a cultivated tissue Oct. 01, 2024
  • Patent Title: Fluid systems, apparatuses, devices and methods of management thereof for cultivating tissue Apr. 16, 2024
  • Patent Title: Tubular prostheses Jul. 13, 2021
  • Patent Title: Tissue-engineered constructs Mar. 16, 2021
  • Patent Title: Tissue-engineered constructs Mar. 02, 2021
  • Patent Title: Methods and apparatuses for forming fibrous tubes Jul. 30, 2019
  • Patent Title: Tubular prostheses Jan. 08, 2019
  • Patent Title: Tubular tissue-engineered constructs May. 23, 2017
  • Patent Title: Tissue-engineered constructs May. 16, 2017
  • Patent Title: Tissue-engineered constructs Jan. 31, 2017
  • Patent Title: Compositions and methods for soft tissue augmentation Jun. 12, 2012
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to HUMA from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
HUMA News

Recent insights relating to HUMA

CNBC Recommendations

Recent picks made for HUMA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in HUMA

HUMA Analyst Ratings

HUMA Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
HUMA Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $HUMA stock a Buy, Sell, or Hold?

  • What is the price target for $HUMA stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

HUMA Top Shareholders
Shareholder
Shares Held
HUMA Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $HUMA stock?

  • Who owns the most shares of $HUMA stock?

  • What funds own $HUMA stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

HUMA Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view HUMA Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About HUMA

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

  • Address Durham, NC
  • Market Cap 158.0 million
  • Employees 184
  • Industrial Classification Biological Products, (No Diagnostic Substances)

Humacyte, Inc. Common Stock (HUMA) Historical Stock Prices

Humacyte, Inc. Common Stock (HUMA) closed at $0.5687 on September 24, 2026. Over the past year its adjusted close ranged from $0.5500 to $2.48. Daily prices go back to December 1, 2020, 1,460 trading days in all.

  • 1 month-18.90%
  • 3 months-8.27%
  • Year to date-40.79%
  • 1 year-66.15%
  • 3 years-80.12%
  • 5 years-95.47%
  • Max-94.12%
See every congressional and insider trade on the HUMA price chart

Quiver Premium charts HUMA's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 24, 2026 0.5599 0.5731 0.5430 0.5687 0.5687 2,835,495
Sep 23, 2026 0.5880 0.5880 0.5556 0.5657 0.5657 3,431,572
Sep 22, 2026 0.5876 0.6079 0.5811 0.5828 0.5828 3,469,805
Sep 21, 2026 0.6000 0.6099 0.5750 0.5900 0.5900 3,406,472
Sep 18, 2026 0.5699 0.6078 0.5699 0.5856 0.5856 6,991,243
Sep 17, 2026 0.5946 0.5980 0.5652 0.5751 0.5751 2,900,290
Sep 16, 2026 0.5582 0.5960 0.5500 0.5700 0.5700 4,958,527
Sep 15, 2026 0.5600 0.5696 0.5400 0.5516 0.5516 3,212,176
Sep 14, 2026 0.5500 0.5749 0.5500 0.5610 0.5610 3,164,573
Sep 11, 2026 0.5759 0.5878 0.5590 0.5676 0.5676 2,264,995
Sep 10, 2026 0.5800 0.5800 0.5600 0.5671 0.5671 2,665,146
Sep 9, 2026 0.5905 0.6000 0.5751 0.5790 0.5790 2,924,791
Sep 8, 2026 0.6095 0.6099 0.5800 0.5949 0.5949 2,401,959
Sep 4, 2026 0.5910 0.6101 0.5828 0.6049 0.6049 2,965,439
Sep 3, 2026 0.6076 0.6099 0.5840 0.5960 0.5960 3,016,735
Sep 2, 2026 0.5711 0.6111 0.5700 0.5966 0.5966 5,178,828
Sep 1, 2026 0.5980 0.6014 0.5700 0.5704 0.5704 16,536,117
Aug 31, 2026 0.6500 0.6500 0.5838 0.6014 0.6014 13,537,584
Aug 28, 2026 0.6900 0.6954 0.6401 0.6501 0.6501 4,921,511
Aug 27, 2026 0.7000 0.7082 0.6870 0.6927 0.6927 2,964,133
Aug 26, 2026 0.7100 0.7119 0.6700 0.6816 0.6816 5,678,050
Aug 25, 2026 0.6630 0.7300 0.6601 0.7012 0.7012 5,920,952
Aug 24, 2026 0.6750 0.6936 0.6424 0.6622 0.6622 3,758,871
Aug 21, 2026 0.6741 0.7000 0.6345 0.6422 0.6422 9,366,430
Aug 20, 2026 0.7074 0.7150 0.6627 0.6814 0.6814 6,648,243
Aug 19, 2026 0.6000 0.7500 0.5964 0.7349 0.7349 21,660,153
Aug 18, 2026 0.5600 0.5893 0.5401 0.5817 0.5817 9,261,658
Aug 17, 2026 0.6098 0.6099 0.5422 0.5606 0.5606 13,740,736
Aug 14, 2026 0.5729 0.6210 0.5261 0.6048 0.6048 33,057,500
Aug 13, 2026 0.6410 0.6775 0.5500 0.5500 0.5500 32,778,698
Aug 12, 2026 0.6438 0.6652 0.6156 0.6650 0.6650 11,169,104
Aug 11, 2026 0.7399 0.7450 0.7100 0.7100 0.7100 3,594,560
Aug 10, 2026 0.7202 0.7499 0.7023 0.7445 0.7445 2,846,622
Aug 7, 2026 0.7128 0.7398 0.7021 0.7182 0.7182 2,277,637
Aug 6, 2026 0.7042 0.7300 0.6835 0.7096 0.7096 1,957,034
Aug 5, 2026 0.7250 0.7316 0.7011 0.7288 0.7288 2,055,294
Aug 4, 2026 0.6802 0.7250 0.6802 0.7122 0.7122 2,910,493
Aug 3, 2026 0.6600 0.7056 0.6500 0.6893 0.6893 3,267,166
Jul 31, 2026 0.6855 0.6899 0.6441 0.6534 0.6534 1,746,680
Jul 30, 2026 0.6457 0.6850 0.6260 0.6716 0.6716 4,087,205
Jul 29, 2026 0.6300 0.6495 0.6150 0.6246 0.6246 3,854,420
Jul 28, 2026 0.6694 0.6796 0.6300 0.6307 0.6307 2,238,964
Jul 27, 2026 0.6405 0.6788 0.6340 0.6741 0.6741 3,825,255
Jul 24, 2026 0.6443 0.6481 0.6211 0.6248 0.6248 2,566,605
Jul 23, 2026 0.6360 0.6650 0.6230 0.6386 0.6386 5,137,091
Jul 22, 2026 0.6667 0.6800 0.6400 0.6446 0.6446 7,781,453
Jul 21, 2026 0.6400 0.7099 0.6400 0.6708 0.6708 8,648,676
Jul 20, 2026 0.6800 0.6800 0.6350 0.6562 0.6562 3,023,952
Jul 17, 2026 0.6530 0.6699 0.6400 0.6647 0.6647 4,008,281
Jul 16, 2026 0.6850 0.6861 0.6350 0.6596 0.6596 8,426,879
Jul 15, 2026 0.7108 0.7270 0.6800 0.6816 0.6816 3,982,366
Jul 14, 2026 0.6800 0.7205 0.6720 0.7072 0.7072 7,742,477
Jul 13, 2026 0.6910 0.7099 0.6800 0.6912 0.6912 7,649,719
Jul 10, 2026 0.7000 0.7399 0.6700 0.6937 0.6937 13,055,056
Jul 9, 2026 0.7384 0.7450 0.7000 0.7003 0.7003 10,114,755
Jul 8, 2026 0.7528 0.7697 0.7150 0.7332 0.7332 7,022,466
Jul 7, 2026 0.7628 0.8000 0.7320 0.7709 0.7709 7,829,703
Jul 6, 2026 0.7300 0.7839 0.7200 0.7706 0.7706 9,492,137
Jul 2, 2026 0.7001 0.7345 0.6935 0.7100 0.7100 12,889,357
Jul 1, 2026 0.7770 0.8200 0.6726 0.6726 0.6726 18,083,654
Jun 30, 2026 0.7710 0.8696 0.7525 0.7804 0.7804 14,311,831
Jun 29, 2026 0.7400 0.8189 0.6725 0.7989 0.7989 36,756,048
Jun 26, 2026 0.6288 0.7970 0.6100 0.7086 0.7086 46,984,521
Jun 25, 2026 0.7000 0.7296 0.6192 0.6200 0.6200 25,464,075
Jun 24, 2026 0.7451 0.7700 0.6400 0.6977 0.6977 29,486,464
Jun 23, 2026 0.8400 0.8600 0.6954 0.7004 0.7004 46,220,877
Jun 22, 2026 0.9250 0.9294 0.8300 0.8393 0.8393 23,584,606
Jun 18, 2026 1.00 1.00 0.9002 0.9244 0.9244 11,323,184
Jun 17, 2026 1.02 1.06 0.9390 0.9689 0.9689 13,798,547
Jun 16, 2026 1.07 1.08 1.01 1.03 1.03 7,073,997
Jun 15, 2026 1.07 1.11 1.06 1.07 1.07 5,692,744
Jun 12, 2026 1.10 1.11 1.05 1.05 1.05 9,087,132
Jun 11, 2026 1.05 1.10 1.00 1.08 1.08 29,497,494
Jun 10, 2026 1.40 1.49 1.31 1.34 1.34 7,975,015
Jun 9, 2026 1.38 1.50 1.32 1.39 1.39 4,746,744
Jun 8, 2026 1.40 1.42 1.35 1.38 1.38 3,780,539
Jun 5, 2026 1.49 1.50 1.33 1.35 1.35 6,432,913
Jun 4, 2026 1.39 1.52 1.38 1.49 1.49 6,604,236
Jun 3, 2026 1.42 1.46 1.35 1.40 1.40 5,495,626
Jun 2, 2026 1.40 1.48 1.36 1.39 1.39 8,980,303
Jun 1, 2026 1.30 1.48 1.29 1.45 1.45 11,099,770
May 29, 2026 1.28 1.34 1.24 1.30 1.30 9,420,696
May 28, 2026 1.15 1.30 1.11 1.28 1.28 11,287,089
May 27, 2026 1.11 1.21 1.10 1.15 1.15 5,846,266
May 26, 2026 1.02 1.12 1.02 1.11 1.11 7,120,931
May 22, 2026 1.01 1.06 0.9901 1.05 1.05 3,766,260
May 21, 2026 0.9222 1.04 0.8900 1.02 1.02 6,807,244
May 20, 2026 0.8412 0.9299 0.8253 0.9172 0.9172 4,351,932
May 19, 2026 0.9000 0.9000 0.8200 0.8253 0.8253 4,185,060
May 18, 2026 0.9500 0.9800 0.8600 0.8984 0.8984 6,547,683
May 15, 2026 1.05 1.05 0.8900 0.9301 0.9301 7,490,280
May 14, 2026 1.15 1.22 1.00 1.00 1.00 10,112,809
May 13, 2026 0.8948 1.18 0.8600 1.13 1.13 26,084,733
May 12, 2026 0.9700 0.9847 0.9100 0.9100 0.9100 4,690,104
May 11, 2026 1.04 1.05 1.00 1.00 1.00 8,062,858
May 8, 2026 1.07 1.09 1.01 1.06 1.06 5,588,500
May 7, 2026 1.02 1.09 0.9461 1.08 1.08 9,368,957
May 6, 2026 0.9052 0.9924 0.8800 0.9833 0.9833 6,062,853
May 5, 2026 0.9600 0.9600 0.8660 0.9019 0.9019 4,050,993
May 4, 2026 0.8700 0.9410 0.8700 0.9248 0.9248 4,454,835
May 1, 2026 0.8312 0.8591 0.8108 0.8553 0.8553 2,029,185
Apr 30, 2026 0.8219 0.8528 0.8001 0.8418 0.8418 2,904,740
Apr 29, 2026 0.8200 0.8374 0.7950 0.8200 0.8200 3,462,702
Apr 28, 2026 0.8250 0.8511 0.7610 0.8475 0.8475 5,281,481
Apr 27, 2026 0.7100 0.8296 0.7000 0.8059 0.8059 8,082,725
Apr 24, 2026 0.7083 0.7221 0.6900 0.7000 0.7000 2,241,515
Apr 23, 2026 0.7055 0.7599 0.6765 0.7081 0.7081 4,523,660
Apr 22, 2026 0.6800 0.7232 0.6664 0.7049 0.7049 4,651,908
Apr 21, 2026 0.6852 0.7129 0.6540 0.6590 0.6590 4,159,226
Apr 20, 2026 0.7000 0.7170 0.6762 0.6875 0.6875 3,914,421
Apr 17, 2026 0.7150 0.7536 0.7011 0.7102 0.7102 5,062,002
Apr 16, 2026 0.7505 0.7599 0.6750 0.6836 0.6836 5,291,556
Apr 15, 2026 0.7101 0.7400 0.7034 0.7361 0.7361 4,428,756
Apr 14, 2026 0.6730 0.7260 0.6730 0.6911 0.6911 4,121,173
Apr 13, 2026 0.6400 0.7000 0.6361 0.6701 0.6701 4,662,507
Apr 10, 2026 0.6107 0.6659 0.6031 0.6454 0.6454 4,666,049
Apr 9, 2026 0.6527 0.6674 0.6070 0.6070 0.6070 4,596,411
Apr 8, 2026 0.6499 0.6700 0.6155 0.6515 0.6515 4,717,408
Apr 7, 2026 0.6267 0.6414 0.6002 0.6069 0.6069 4,829,490
Apr 6, 2026 0.6646 0.7063 0.6452 0.6500 0.6500 5,229,850
Apr 2, 2026 0.5813 0.6575 0.5750 0.6424 0.6424 4,820,077
Apr 1, 2026 0.6316 0.6316 0.5700 0.5919 0.5919 6,146,537
Mar 31, 2026 0.5890 0.6253 0.5601 0.6067 0.6067 7,097,121
Mar 30, 2026 0.6988 0.6988 0.5469 0.5745 0.5745 15,716,424
Mar 27, 2026 0.7406 0.7699 0.6682 0.6756 0.6756 14,586,555
Mar 26, 2026 0.8300 0.9000 0.7784 0.7784 0.7784 6,914,158
Mar 25, 2026 0.8300 0.8576 0.7944 0.8230 0.8230 7,502,340
Mar 24, 2026 0.8480 0.8600 0.7701 0.7944 0.7944 7,755,689
Mar 23, 2026 0.8326 0.8799 0.7865 0.8503 0.8503 13,437,286
Mar 20, 2026 0.9027 0.9100 0.7010 0.7829 0.7829 31,558,370
Mar 19, 2026 0.9760 0.9800 0.8100 0.8541 0.8541 52,324,316
Mar 18, 2026 1.17 1.17 1.06 1.06 1.06 4,306,145
Mar 17, 2026 1.12 1.17 1.12 1.16 1.16 2,788,580
Mar 16, 2026 1.17 1.21 1.09 1.12 1.12 4,246,644
Mar 13, 2026 1.15 1.22 1.14 1.16 1.16 2,289,297
Mar 12, 2026 1.19 1.21 1.13 1.14 1.14 2,958,432
Mar 11, 2026 1.25 1.26 1.18 1.19 1.19 3,355,200
Mar 10, 2026 1.22 1.31 1.22 1.24 1.24 6,203,171
Mar 9, 2026 1.11 1.23 1.09 1.20 1.20 6,595,827
Mar 6, 2026 1.09 1.15 1.08 1.11 1.11 3,364,938
Mar 5, 2026 1.16 1.16 1.08 1.09 1.09 4,605,966
Mar 4, 2026 1.11 1.22 1.08 1.15 1.15 5,103,472
Mar 3, 2026 1.10 1.12 1.06 1.07 1.07 2,662,658
Mar 2, 2026 1.09 1.13 1.07 1.12 1.12 2,243,182
Feb 27, 2026 1.20 1.21 1.10 1.11 1.11 4,246,717
Feb 26, 2026 1.17 1.26 1.16 1.23 1.23 6,066,096
Feb 25, 2026 1.11 1.21 1.11 1.16 1.16 4,742,616
Feb 24, 2026 1.13 1.14 1.04 1.12 1.12 5,151,512
Feb 23, 2026 1.12 1.17 1.09 1.14 1.14 3,508,248
Feb 20, 2026 1.12 1.15 1.10 1.13 1.13 3,089,087
Feb 19, 2026 1.09 1.16 1.07 1.15 1.15 4,091,725
Feb 18, 2026 1.13 1.14 1.06 1.08 1.08 4,719,003
Feb 17, 2026 1.03 1.16 1.03 1.14 1.14 7,222,166
Feb 13, 2026 1.01 1.04 0.9849 1.01 1.01 3,479,928
Feb 12, 2026 1.01 1.04 0.9808 1.01 1.01 6,879,872
Feb 11, 2026 1.07 1.08 0.9631 1.01 1.01 8,950,905
Feb 10, 2026 1.25 1.29 1.04 1.05 1.05 13,237,645
Feb 9, 2026 1.02 1.29 1.00 1.22 1.22 26,871,414
Feb 6, 2026 0.9278 0.9579 0.9020 0.9383 0.9383 2,435,572
Feb 5, 2026 0.9600 0.9638 0.8800 0.8862 0.8862 4,082,001
Feb 4, 2026 0.9902 1.00 0.9300 0.9582 0.9582 3,409,282
Feb 3, 2026 1.01 1.03 0.9700 0.9990 0.9990 2,935,405
Feb 2, 2026 0.9995 1.02 0.9508 1.02 1.02 3,100,558
Jan 30, 2026 1.02 1.06 0.9844 0.9977 0.9977 3,070,497
Jan 29, 2026 1.01 1.05 0.9750 1.03 1.03 2,693,529
Jan 28, 2026 1.04 1.05 0.9810 1.00 1.00 3,173,774
Jan 27, 2026 1.03 1.03 0.9700 1.03 1.03 3,829,539
Jan 26, 2026 1.05 1.06 1.00 1.02 1.02 4,027,678
Jan 23, 2026 1.12 1.13 1.04 1.05 1.05 4,970,036
Jan 22, 2026 1.02 1.15 1.01 1.12 1.12 9,115,202
Jan 21, 2026 1.03 1.05 0.9581 0.9800 0.9800 8,941,075
Jan 20, 2026 1.10 1.10 1.02 1.02 1.02 4,873,208
Jan 16, 2026 1.13 1.16 1.08 1.11 1.11 3,847,164
Jan 15, 2026 1.15 1.15 1.08 1.10 1.10 3,715,246
Jan 14, 2026 1.11 1.15 1.08 1.14 1.14 3,521,174
Jan 13, 2026 1.13 1.15 1.08 1.11 1.11 4,608,694
Jan 12, 2026 1.17 1.18 1.11 1.13 1.13 5,481,724
Jan 9, 2026 1.19 1.23 1.16 1.17 1.17 2,754,274
Jan 8, 2026 1.20 1.23 1.15 1.17 1.17 4,707,427
Jan 7, 2026 1.09 1.25 1.09 1.20 1.20 9,940,758
Jan 6, 2026 1.08 1.12 1.05 1.08 1.08 4,500,895
Jan 5, 2026 1.01 1.08 1.01 1.06 1.06 5,780,073
Jan 2, 2026 0.9793 1.04 0.9500 0.9750 0.9750 4,301,055
Dec 31, 2025 1.01 1.01 0.9100 0.9605 0.9605 10,290,697
Dec 30, 2025 1.02 1.03 0.9900 1.01 1.01 6,448,864
Dec 29, 2025 1.04 1.06 1.01 1.02 1.02 4,842,115
Dec 26, 2025 1.09 1.10 1.04 1.07 1.07 3,668,531
Dec 24, 2025 1.13 1.15 1.06 1.08 1.08 2,482,357
Dec 23, 2025 1.06 1.15 1.04 1.13 1.13 5,448,423
Dec 22, 2025 1.12 1.16 1.06 1.07 1.07 6,441,457
Dec 19, 2025 1.13 1.16 1.10 1.11 1.11 7,280,180
Dec 18, 2025 1.10 1.17 1.09 1.11 1.11 4,979,432
Dec 17, 2025 1.10 1.13 1.06 1.07 1.07 5,663,344
Dec 16, 2025 1.19 1.19 1.11 1.12 1.12 4,938,748
Dec 15, 2025 1.29 1.30 1.17 1.18 1.18 5,935,526
Dec 12, 2025 1.32 1.34 1.29 1.31 1.31 2,131,677
Dec 11, 2025 1.26 1.34 1.26 1.31 1.31 3,342,032
Dec 10, 2025 1.25 1.29 1.23 1.27 1.27 3,216,798
Dec 9, 2025 1.29 1.32 1.22 1.27 1.27 4,448,762
Dec 8, 2025 1.25 1.30 1.21 1.29 1.29 5,756,646
Dec 5, 2025 1.29 1.31 1.23 1.23 1.23 3,958,553
Dec 4, 2025 1.29 1.33 1.26 1.30 1.30 3,084,875
Dec 3, 2025 1.29 1.31 1.23 1.29 1.29 3,269,793
Dec 2, 2025 1.30 1.31 1.25 1.26 1.26 3,363,978
Dec 1, 2025 1.33 1.34 1.26 1.28 1.28 3,767,818
Nov 28, 2025 1.34 1.38 1.32 1.35 1.35 2,269,073
Nov 26, 2025 1.31 1.35 1.30 1.33 1.33 3,307,587
Nov 25, 2025 1.27 1.32 1.24 1.32 1.32 3,064,806
Nov 24, 2025 1.23 1.29 1.21 1.28 1.28 5,401,854
Nov 21, 2025 1.11 1.25 1.09 1.22 1.22 6,038,626
Nov 20, 2025 1.19 1.26 1.10 1.12 1.12 6,449,974
Nov 19, 2025 1.23 1.23 1.13 1.17 1.17 4,708,061
Nov 18, 2025 1.12 1.21 1.12 1.20 1.20 4,036,364
Nov 17, 2025 1.21 1.21 1.11 1.13 1.13 7,671,816
Nov 14, 2025 1.15 1.28 1.13 1.23 1.23 5,901,018
Nov 13, 2025 1.23 1.27 1.17 1.19 1.19 7,169,139
Nov 12, 2025 1.43 1.43 1.22 1.25 1.25 8,180,144
Nov 11, 2025 1.36 1.37 1.28 1.28 1.28 5,139,112
Nov 10, 2025 1.39 1.42 1.32 1.35 1.35 3,917,475
Nov 7, 2025 1.30 1.34 1.22 1.33 1.33 5,847,583
Nov 6, 2025 1.47 1.47 1.26 1.31 1.31 6,368,691
Nov 5, 2025 1.49 1.49 1.42 1.45 1.45 3,297,036
Nov 4, 2025 1.55 1.56 1.46 1.46 1.46 4,353,648
Nov 3, 2025 1.68 1.68 1.58 1.59 1.59 3,321,783
Oct 31, 2025 1.65 1.67 1.60 1.67 1.67 3,262,612
Oct 30, 2025 1.68 1.70 1.60 1.62 1.62 3,644,778
Oct 29, 2025 1.70 1.78 1.68 1.69 1.69 4,694,051
Oct 28, 2025 1.68 1.74 1.65 1.70 1.70 2,894,013
Oct 27, 2025 1.72 1.74 1.66 1.68 1.68 2,269,425
Oct 24, 2025 1.72 1.73 1.68 1.71 1.71 2,691,761
Oct 23, 2025 1.64 1.73 1.64 1.69 1.69 3,057,138
Oct 22, 2025 1.72 1.75 1.61 1.62 1.62 6,344,118
Oct 21, 2025 1.80 1.80 1.71 1.73 1.73 3,856,488
Oct 20, 2025 1.79 1.90 1.77 1.81 1.81 8,110,051
Oct 17, 2025 1.67 1.75 1.64 1.72 1.72 4,412,880
Oct 16, 2025 1.77 1.79 1.67 1.70 1.70 4,325,412
Oct 15, 2025 1.80 1.82 1.70 1.77 1.77 4,608,221
Oct 14, 2025 1.71 1.82 1.67 1.79 1.79 9,330,634
Oct 13, 2025 1.60 1.77 1.59 1.76 1.76 9,527,305
Oct 10, 2025 1.63 1.64 1.55 1.56 1.56 7,477,395
Oct 9, 2025 1.67 1.68 1.58 1.64 1.64 9,300,170
Oct 8, 2025 1.68 1.71 1.62 1.69 1.69 13,189,032
Oct 7, 2025 1.97 1.97 1.61 1.65 1.65 36,320,678
Oct 6, 2025 2.30 2.55 2.18 2.48 2.48 11,155,994
Oct 3, 2025 1.81 2.22 1.79 2.10 2.10 9,254,186
Oct 2, 2025 1.78 1.79 1.70 1.79 1.79 2,163,366
Oct 1, 2025 1.71 1.79 1.70 1.76 1.76 2,029,305
Sep 30, 2025 1.73 1.78 1.69 1.74 1.74 2,284,974
Sep 29, 2025 1.73 1.79 1.70 1.73 1.73 1,746,671
Sep 26, 2025 1.60 1.74 1.59 1.73 1.73 2,145,503
Sep 25, 2025 1.65 1.67 1.61 1.61 1.61 4,257,515
Sep 24, 2025 1.72 1.82 1.68 1.68 1.68 2,648,510

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Humacyte, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at HUMA, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation